Trial Profile
A Dose-Escalation, Safety And Feasibility Study Of Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 27 Nov 2014
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Seizures
- Focus Therapeutic Use
- Acronyms LVT1
- 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Jan 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 17 Aug 2012 New trial record